Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$17.73 -0.49 (-2.72%)
As of: Oct 2, 2026 · 11:40 AM EDT

Syndax Pharmaceuticals (SNDX) Net Equity Issued and Repurchased (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) posted Net Equity Issued and Repurchased of $8.76 million for Q2 2026, compared with $468,000 a year earlier and up 17.4% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Syndax Pharmaceuticals was $27.34 million, up 307.1% year-over-year; for FY2025, it was $12.14 million, up 51.7% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 12.8% (FY2020 to FY2025).
  • In prior years, Syndax Pharmaceuticals' Net Equity Issued and Repurchased was $8 million in FY2024 (+56.0%), $5.13 million in FY2023 (-96.8%), $162 million in FY2022 (+99.5%) and $81.2 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since Q2 2022.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in four of the last five quarters, with growth averaging 38.6%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q1 2023, with growth of 389.9%; the weakest was Q2 2023, with a decline of 94.0%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $7.46 million (Q1 2026), $5.31 million (Q4 2025) and $5.81 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Syndax Pharmaceuticals 1.68 Bn -53.94 Mn 69.58 Mn 8.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.76 Mn
Mar 31, 2026 7.46 Mn
Dec 31, 2025 5.31 Mn
Sep 30, 2025 5.81 Mn
Jun 30, 2025 468,000.00
Mar 31, 2025 545,000.00
Dec 31, 2024 3.14 Mn
Sep 30, 2024 2.56 Mn
Jun 30, 2024 439,000.00
Mar 31, 2024 1.86 Mn
Dec 31, 2023 112,000.00
Sep 30, 2023 1.59 Mn
Jun 30, 2023 1.15 Mn
Mar 31, 2023 2.28 Mn
Dec 31, 2022 -7.93 Mn
Jun 30, 2022 18.96 Mn
Mar 31, 2022 465,000.00
Dec 31, 2021 1.21 Mn
Jun 30, 2021 4.25 Mn
Mar 31, 2021 881,000.00
API Access

Syndax Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SNDX&period=max&api_key=YOUR_API_KEY